Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Progressive Corp (PGR) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

Progressive CorpTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Progressive Corp vs Vir Biotechnology Inc. Common Stock — how do they compare? Progressive Corp trades at $214.49 (market cap $129.36B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Progressive Corp is far larger — about 71.9× Vir Biotechnology Inc. Common Stock's market cap, and Progressive Corp pays a 0.18% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Progressive Corp for 81 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

PGRVIR
Market Cap
$129.36B$1.80B
Volume
3,501,6191,782,836
Sector
FinancialsHealth
52-Week High
$236.18$11.78
52-Week Low
$190.40$5.12
Typical Hold Time
81 Days0 Days
Enterprise Value
$137.57B$1.36B
Dividend Yield
0.18%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Progressive Corp

PGR trades at $213.46, down 3.1% on the day, amid mixed earnings results with recent Q3 2026 miss. The stock shows strong fundamentals with revenue growth from $49.6B in 2022 to $87.6B in 2025 and net income margin of 12.85%. Technicals are bullish with moving averages supporting upside, while RSI levels indicate potential overbought conditions. Recent news highlights Progressive's telematics edge and inclusion in dividend-focused articles.

Outlook remains positive with analyst consensus target of $222.23 implying ~4% upside. Key opportunities include sustained underwriting strength and dividend reliability, but risks involve competitive pressures in auto insurance and earnings volatility. The stock's valuation at P/E of 11.18 appears reasonable relative to profitability metrics.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

PGR
100% Buy0% Sell
Avg holding period · 81 Days
VIR
51% Buy49% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Progressive Corp

Progressive underwrites private and commercial auto insurance and specialty lines

Read more on PGR →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →